RCM
ALIM

Rotella Capital Management’s Alimera Sciences ALIM Stock Holding History

Rotella Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-922
Closed -$83K – 410
2014
Q2 		$83K Buy
+922
New +$81.9K 0.07% 250

Other funds holding ALIM

PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Rotella Capital Management's ALIM Position: Q3 2014 in Review

Rotella Capital Management sold out of Alimera Sciences (ALIM) in Q3 2014, closing a stake of 922 shares — an estimated $83K sold.

Rotella Capital Management first reported a position in ALIM in Q2 2014 and held it in 1 quarter. The position peaked at $83K in Q2 2014. 60 funds tracked by Wall St. Rank hold ALIM as of Q3 2014.

  • Rotella Capital Management reported no remaining Alimera Sciences position as of Q3 2014 after selling out during the quarter.
  • Rotella Capital Management sold 922 Alimera Sciences shares in Q3 2014, an estimated $83K.
  • Rotella Capital Management first reported a position in Alimera Sciences in Q2 2014 and held it in 1 quarter.
  • Rotella Capital Management's Alimera Sciences position peaked at $83K in Q2 2014.
  • 60 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2014.

Based on Rotella Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.